Skip to main content

Trinity College Dublin, The University of Dublin

Menu Search


Trinity College Dublin By using this website you consent to the use of cookies in accordance with the Trinity cookie policy. For more information on cookies see our cookie policy.

      
Profile Photo

Dr. Mark Ward

Medical Scientist (Histopathology)
      
Profile Photo

Dr. Mark Ward

Medical Scientist (Histopathology)

 


Dr. Mark Ward graduated from Trinity College Dublin in 2012 with a BA (Mod.) in Biochemistry. Following this, he completed his PhD in 2016 in the Department of Pharmacology and Therapeutics in Trinity College Dublin investigating the role of Protein Phosphatase 2A (PP2A) in the regulation of matrix metalloproteinases in liver cancer. His current research focuses on the area of "Liquid Biopsy" and the isolation and molecular characterisation of rare circulating tumour cells (CTCs) and the identification of somatic tumour specific mutations in circulating tumour DNA (ctDNA). His research interests also include the role of platelets/immune cells in mediating cancer metastasis and the mechanisms of tumour associated thrombosis in gynaecological cancers. https://orcid.org/0000-0002-9356-7246
  BREAST CANCER   cancer inflammation   Circulating Tumour Cells   ctDNA   Extracellular vesicles (EVs)   Gynaecological cancer   INFLAMMATION   Inflammation and coagulation syndromes   Liquid Biopsy   METASTASIS   NEUTROPHILS   Ovarian Cancer   OVARIAN VEIN-THROMBOSIS   PLATELETS   THROMBIN
Details Date From Date To
European Association for Cancer Research 2018 Present
The Irish Society for Gynaecological Oncology (ISGO) 2016 2023
Hindes MT, McElligott AM, Best OG, Ward MP, Selemidis S, Miles MA, Nturubika BD, Gregory PA, Anderson PH, Logan JM, Butler LM, Waugh DJ, O'Leary JJ, Hickey SM, Thurgood LA, Brooks DA., Metabolic reprogramming, malignant transformation and metastasis: Lessons from chronic lymphocytic leukaemia and prostate cancer., Cancer letters, 611, 2025, p217441 , Journal Article, PUBLISHED  TARA - Full Text  DOI
Ward MP, Ibrahim EM, O'Toole SA, Marchocki Z, O'Leary JJ, Saadeh FA, Norris LA., Chemotherapy alters thrombomodulin and factor VIIIc expression resulting in acquired activated protein C resistance and enhanced thrombin generation in cancer associated thrombosis., Thrombosis research, 246, 2024, p109251 , Journal Article, PUBLISHED  DOI
Ward, Mark P., O'Toole, Sharon A., O'Leary, John J., Potential role of the CD39-CD73 ATP-adenosine pathway in platelet mediated dissemination of circulating tumour cells, British Journal of Cancer, 2024, Journal Article, PUBLISHED  DOI
M Saini, Volga, Oner, Ezgi, Ward, Mark P., Hurley, Sinead, Henderson, Brian David, Lewis, Faye, Finn, Stephen P., Fitzmaurice, Gerard J., O'Leary, John J., O'Toole, Sharon, O'Driscoll, Lorraine, Gately, Kathy, A comparative study of circulating tumor cell isolation and enumeration technologies in lung cancer, Molecular Oncology, 2024, Journal Article, PUBLISHED  DOI
Lewis F, Beirne J, Henderson B, Norris L, Cadoo K, Kelly T, Martin C, Hurley S, Kanjuga M, O'Driscoll L, Gately K, Oner E, Saini V, Brooks D, Selemidis S, Kamran W, Haughey N, Maguire P, O'Gorman C, Saadeh FA, Ward MP, O'Leary JJ, O'Toole SA., Unravelling the biological and clinical challenges of circulating tumour cells in epithelial ovarian carcinoma., Cancer letters, 2024, p217279 , Journal Article, PUBLISHED  DOI
Nturubika BD, Logan J, Johnson IRD, Moore C, Li KL, Tang J, Lam G, Parkinson-Lawrence E, Williams DB, Chakiris J, Hindes M, Brooks RD, Miles MA, Selemidis S, Gregory P, Weigert R, Butler L, Ward MP, Waugh DJJ, O'Leary JJ, Brooks DA., Components of the Endosome-Lysosome Vesicular Machinery as Drivers of the Metastatic Cascade in Prostate Cancer., Cancers, 17, (1), 2024, p43 , Journal Article, PUBLISHED  DOI
Bates M, Mohamed BM, Ward MP, Kelly TE, O'Connor R, Malone V, Brooks R, Brooks D, Selemidis S, Martin C, O'Toole S, O'Leary JJ., Circulating tumour cells: The Good, the Bad and the Ugly., Biochim Biophys Acta Rev Cancer, 1878, (2), 2023, p188863 , Journal Article, PUBLISHED  TARA - Full Text  DOI
Mohamed BM, Ward MP, Bates M, Spillane CD, Kelly T, Martin C, Gallagher M, Heffernan S, Norris L, Kennedy J, Saadeh FA, Gleeson N, Brooks DA, Brooks RD, Selemidis S, O'Toole S, O'Leary JJ., Ex vivo expansion of circulating tumour cells (CTCs)., Scientific reports, 13, (1), 2023, p3704 - 3704, Journal Article, PUBLISHED  DOI
Logan JM, Hopkins AM, Martini C, Sorvina A, Tewari P, Prabhakaran S, Huzzell C, Johnson IRD, Hickey SM, Ung BS, Lazniewska J, Brooks RD, Moore CR, Caruso MC, Karageorgos L, Martin CM, O'Toole S, Bogue Edgerton L, Ward MP, Bates M, Selemidis S, Esterman A, Heffernan S, Keegan H, NĂ­ Mhaolcatha S, O'Connor R, Malone V, Carter M, Ryan K, Clarke A, Brady N, Klebe S, Samaratunga H, Delahunt B, Sorich MJ, Moretti K, Butler LM, O'Leary JJ, Brooks DA., Prediction of Prostate Cancer Biochemical and Clinical Recurrence Is Improved by IHC-Assisted Grading Using Appl1, Sortilin and Syndecan-1., Cancers, 15, (12), 2023, p3215 , Journal Article, PUBLISHED  DOI
Lazniewska J, Li KL, Johnson IRD, Sorvina A, Logan JM, Martini C, Moore C, Ung BS, Karageorgos L, Hickey SM, Prabhakaran S, Heatlie JK, Brooks RD, Huzzell C, Warnock NI, Ward MP, Mohammed B, Tewari P, Martin C, O'Toole S, Edgerton LB, Bates M, Moretti P, Pitson SM, Selemidis S, Butler LM, O'Leary JJ, Brooks DA., Dynamic interplay between sortilin and syndecan-1 contributes to prostate cancer progression., Scientific reports, 13, (1), 2023, p13489 , Journal Article, PUBLISHED  DOI
  

Page 1 of 4
Mark P. Ward, Bashir M. Mohamed, Laura Kane, Mark Bates, Janina Berghoff, Cathy L. Spillane, Tanya Kelly, John Kennedy, Feras A. Saadeh, Karsten Hokamp, Noreen Gleeson, Orla Sheils, Cara Martin, Michael Gallagher, Sean Hannify, Eric P. Dixon, Sharon A. O'Toole and John J. O'Leary, Influence of platelets and neutrophils on circulating tumour cells, AACR Annual Meeting , Philadelphia, PA, 2020; April 27-28, 80, (16), American Association for Cancer Research, 2020, Poster, PUBLISHED

  


Liquid Biopsy (CTCs, ctDNA, EVs) in cancer, cancer associated thrombosis and platelet/immune cell mediated cancer metastasis.